Filtered By:
Drug: Lithium
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 11675 results found since Jan 2013.
Application of biomass derived products in mid-size automotive industries: A review
Chemosphere. 2021 Oct;280:130723. doi: 10.1016/j.chemosphere.2021.130723. Epub 2021 May 4.ABSTRACTThe automotive industry is directly affected by the shortage of fossil fuels and the excessive pollution resulting from crude oil-based fuels has many adverse effects on the environment. The search for a greener and sustainable source of materials and fuels to power automobiles has ultimately led to the usage of biomass and biobased sources as the main precursor due to its graft availability and renewability. Biobased fuels developed have been shown to easily blend in with the existing automobile engines and to provide sustain...
Source: Chemosphere - June 24, 2021 Category: Chemistry Authors: S M Prasanth P Senthil Kumar S Harish M Rishikesh Sonil Nanda Dai-Viet N Vo Source Type: research
Scopolamine prevents aberrant mossy fiber sprouting and facilitates remission of epilepsy after brain injury
Neurobiol Dis. 2021 Jul 16:105446. doi: 10.1016/j.nbd.2021.105446. Online ahead of print.ABSTRACTPrevention or modification of acquired epilepsy in patients at risk is an urgent, yet unmet, clinical need. Following acute brain insults, there is an increased risk of mesial temporal lobe epilepsy (mTLE), which is often associated with debilitating comorbidities and reduced life expectancy. The latent period between brain injury and the onset of epilepsy may offer a therapeutic window for interfering with epileptogenesis. The pilocarpine model of mTLE is widely used in the search for novel antiepileptogenic treatments. Recent...
Source: Neurobiology of Disease - July 19, 2021 Category: Neurology Authors: Sebastian Meller Christopher K äufer Bj örn Gailus Claudia Brandt Wolfgang L öscher Source Type: research
In-situ characterization of discharge products of lithium-oxygen battery using Flow Electrochemical Atomic Force Microscopy
Ultramicroscopy. 2021 Aug 10;230:113369. doi: 10.1016/j.ultramic.2021.113369. Online ahead of print.ABSTRACTThe increasing interest in lithium-oxygen batteries (LOB), having the highest theoretical energy densities among the advanced lithium batteries, has triggered the search for in-situ characterization techniques, including Electrochemical Atomic Force Microscopy (EC-AFM). In this work we addressed the characterization of the formation and decomposition of lithium peroxide (Li2O2) on a carbon cathode using a modified AFM technique, called Flow Electrochemical Atomic Force Microscopy (FE-AFM), where an oxygen-saturated s...
Source: Ultramicroscopy - August 16, 2021 Category: Laboratory Medicine Authors: Henry A Cort és Horacio R Corti Source Type: research
Lamotrigine in the maintenance treatment of bipolar disorder
CONCLUSIONS: Low- to moderate-certainty evidence collectively suggests that lamotrigine may be superior to placebo as a treatment modality for bipolar disorder. In comparison to lithium, people with bipolar disorder seem to tolerate lamotrigine better in the long run; however, the demonstrated efficacy in the maintenance of bipolar disorder was similar between the two groups.PMID:34523118 | DOI:10.1002/14651858.CD013575.pub2
Source: Cochrane Database of Systematic Reviews - September 15, 2021 Category: General Medicine Authors: Yasuhiko Hashimoto Kazumasa Kotake Norio Watanabe Takashi Fujiwara Shinji Sakamoto Source Type: research
Combined treatment of myo-inositol and d-chiro-inositol (80:1) as a therapeutic approach to restore inositol eumetabolism in patients with bipolar disorder taking lithium and valproic acid
CONCLUSIONS: Considering the iatrogenic depletion of inositols, the tailored ratio 80:1 in favour of myo-ins, may become a safe and effective strategy to counteract side effects, by providing a large amount of myo-ins and an adequate one of d-chiro-ins. The clinical dosage of inositols used as dietary supplementation is 4 grams/daily, and it may allow the recovery of the side effects and improve patients' QoL, without reducing the central therapeutic effect of the pharmacological therapy.PMID:34533796 | DOI:10.26355/eurrev_202109_26657
Source: European Review for Medical and Pharmacological Sciences - September 17, 2021 Category: Drugs & Pharmacology Authors: L Janiri F D'Ambrosio C Di Lorenzo Source Type: research
